IP Library › Granted Patent US 12,514,637
Granted Patent B2
US 12,514,637 · App. 18/608,719 · Granted Jan 6, 2026

Process for respiratory rehabilitation treatment

Inventor: Scott Nagy (Sheffield Village, OH)
Assignee: ARETÉ AIRWAY SOLUTIONS, LLC
A61B18/22A61M37/0015A61B2018/00321A61B2018/00577A61M2037/0023A61M2037/0061A61M2202/0415A61M2202/0439A61M2202/045A61M2202/048A61M2202/09
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,514,637
App. No.
18/608,719
Granted
Jan 6, 2026
Kind
B2
Abstract

A process for respiratory rehabilitation treatment, the process comprises treating a patient with a laser, resurfacing the treatment location by applying pulses of laser light. The process comprises treating a patient with administering an injection, injecting a primary injection solution into an injection location and injecting a secondary injection solution comprises at least a concentrate solution into an injection location. This process treats patients with breathing difficulties with injection of PRP and/or PRF into the soft palate and surrounding tissue. The treatment may be combined with CO2 and/or Nd-YAG laser treatment.

Claims (39)

1 . A process for respiratory rehabilitation treatment, the process comprising:

treating a user with a laser, wherein the laser comprises a scope, wherein the scope comprises a filter configured to attenuate a frequency of the laser, wherein the scope is configured to produce a real-time visual feed, wherein the scope is further configured to perform real-time area identification, wherein the real-time area identification comprises:

processing real-time visual feed from the scope;

identifying target regions using the real-time visual feed; and

providing feedback, wherein the feedback comprises overlaying guidelines onto the real-time visual feed indicating a treatment location;

wherein the laser comprises an integrated sensor mechanism configured to adjust an operation of the laser as a function of a detected target energy delivery, wherein treating comprises:

injecting the treatment location with a local anesthetic; and

resurfacing the treatment location by applying pulses of laser light;

administering an injection, wherein administering comprises:

formulating a primary injection solution, wherein formulating the primary injection solution comprises:

acquiring a biological sample relating to a user; and

collecting the primary injection solution from the biological sample;

injecting the primary injection solution into an injection location relating to the user;

formulating a secondary injection solution, wherein the secondary injection solution comprises at least a concentrate solution; and

administering the secondary injection solution.

2 . The process of claim 1 , wherein the laser comprises a carbon dioxide laser.

3 . The process of claim 1 , wherein the laser comprises a neodymium-doped yttrium aluminum garnet laser.

4 . The process of claim 1 , wherein resurfacing the treatment location comprises:

ablation of a target tissue;

removal of the target tissue; and

modification of the target tissue at the treatment location.

5 . The process of claim 1 , wherein acquiring the biological sample comprises drawing blood sample.

6 . The process of claim 1 , wherein collecting the primary injection solution comprises centrifugation.

7 . The process of claim 1 , wherein the primary injection solution comprises extracting a buffy coat.

8 . The process of claim 7 , wherein extracting the buffy coat comprises:

removing of concentrated leukocyte band, plasma, and concentrated red blood cells;

removing the buffy coat from the biological sample.

9 . The process of claim 1 , wherein the injection location comprises injection in a soft palate.

10 . The process of claim 1 , wherein the primary injection solution comprises undifferentiated cells.

11 . The process of claim 1 , wherein the primary injection solution comprises growth cells.

12 . The process of claim 1 , wherein the primary injection solution comprises white blood cells.

13 . The process of claim 1 , wherein administering the secondary injection solution comprises using a syringe.

14 . The process of claim 13 , wherein the secondary injection solution comprises Platelet Rich Plasma.

15 . The process of claim 13 , wherein the secondary injection solution comprises Platelet Rich Fibrin.

16 . The process of claim 1 , wherein injecting the primary injection solution comprises a micro-needling to the treatment location.

17 . The process of claim 16 , wherein the micro-needling comprises controlled injecting velocity.

18 . The process of claim 1 , wherein the process comprises treating a user with a laser and an injection.

19 . The process of claim 1 , wherein the process comprises treating a user with a laser and a primary injection solution.

20 . The process of claim 1 , wherein the process comprises treating a user with a laser and a secondary injection solution.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 24, 2024
From: NAGY, SCOTT
To: ARETÉ AIRWAY SOLUTIONS, LLC
Reel/Frame 067516/0158 →
Continuity (2)
Provisional Application 63498323 · Apr 26, 2023
Related Publication 20240358434A1 · Oct 31, 2024
References Cited (8)
US 8921037B2 · Han · 2014 [cited by applicant]
US 10034996B2 · Lemper · 2018 [cited by applicant]
US 10639245B2 · Mihajlova et al. · 2020 [cited by applicant]
US 10772824B2 · Najafi · 2020 [cited by applicant]
US 20110130706A1 · Kellogg · 2011 [cited by examiner]
US 20120065551A1 · Aviad · 2012 [cited by examiner]
US 20170028137A1 · Mirabito · 2017 [cited by examiner]
US 20220361940A1 · Chang · 2022 [cited by examiner]